Form 8-K - Current report:
SEC Accession No. 0001013606-20-000084
Filing Date
2020-05-11
Accepted
2020-05-11 16:07:39
Documents
5
Period of Report
2020-05-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K Q1 2020 EARNINGS RELEASE form_8-kxq12020xearningsxr.htm 8-K 62682
2 EXHIBIT 10.1 PPP PROMISSORY NOTE ex101promissorynotedatedma.htm EX-10.1 49171
3 EXHIBIT 10.2 AMENDMENT TO DEERFIELD FACILITY AGREEMENT DATED MAY 4, 2020 ex102amendmenttofacilityag.htm EX-10.2 48594
4 EXHIBIT 99.1 Q1 2020 PRESS RELEASE ex991pressreleaseq12020.htm EX-99.1 178951
5 ELGX LOGO elgx_logoa16.jpg GRAPHIC 52538
  Complete submission text file 0001013606-20-000084.txt   401783
Mailing Address 2 MUSICK IRVINE CA 92618
Business Address 2 MUSICK IRVINE CA 92618 9495984741
ENDOLOGIX INC /DE/ (Filer) CIK: 0001013606 (see all company filings)

EIN.: 680328265 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28440 | Film No.: 20864809
SIC: 3841 Surgical & Medical Instruments & Apparatus